LATE-BREAKING TRIALS | SESSION TWO

Sunday, February 26, 2023

8:00 AM – 9:00 AM ET

Moderator(s)

Robert A. Byrne, MD, BCh, PhD

Director of Cardiology
Mater Private Hospital, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Dublin, Ireland

No relationships to disclose
Gregg W. Stone, MD, FACC, MSCAI (he/him/his)

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)

Panel Discussant(s)

Alexandre A. Abizaid, MD, PhD

Director of Invasive Cardiology
Incor
SÃO PAULO, Sao Paulo, Brazil

Disclosure(s): Boston Scientific: Proctor (Ongoing); Elixir Medical: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
George Dangas, MD, MACC, MSCAI

PROFESSOR OF CARDIOLOGY
The Mount Sinai Hospital
New York, New York, United States

Disclosure information not submitted.
Aloke V. Finn, MD

Medical Director CVPath/Assoc. Prof. Of Medicine University of Maryland
CVPath
Gaithersburg, Maryland, United States

Disclosure(s): Acotec: Grant/Research Support (Ongoing); BD Bard: Grants/Research Support Recipient (Ongoing); Boston Scientific: Grant/Research Support (Ongoing), Honoraria (Ongoing); Concept Medical: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Grants/Research Support Recipient (Ongoing); inari: Grants/Research Support Recipient (Ongoing); MedAlliance: Grants/Research Support Recipient (Ongoing), Honoraria (Ongoing); Medtronic Cardiovascular: Contracted Research (Ongoing), Honoraria (Ongoing); Recor: Grants/Research Support Recipient (Ongoing); Terumo Corporation: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Kendra J. Grubb, MD

Surgical Director, Structural Heart and Valve Center
Emory University
Atlanta, Georgia, United States

Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)
Michael H. Joner, MD

Associate Professor Interventional Cardiology
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany

Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 22, 2022); Alchimedics S.A.S.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 15, 2022); Biotronik: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiac Dimensions: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing); InfraRedx: Grant/Research Support (Ongoing); ReCor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 19, 2022); Shockwave: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Veryan: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing)
Spencer B. King, III, MD, MACC, MSCAI

Professor of Medicine Emeritus
Emory University
Atlanta, Georgia, United States

No relationships to disclose
TM

Thomas E. MacGillivray, MD

Physician Executive Director and Chair, Cardiac Surgery
MedStar Health, MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure information not submitted.

Disclosure(s):

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)

Alexandre A. Abizaid, MD, PhD: Boston Scientific: Proctor (Ongoing); Elixir Medical: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Aloke V. Finn, MD: Acotec: Grant/Research Support (Ongoing); BD Bard: Grants/Research Support Recipient (Ongoing); Boston Scientific: Grant/Research Support (Ongoing), Honoraria (Ongoing); Concept Medical: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Grants/Research Support Recipient (Ongoing); inari: Grants/Research Support Recipient (Ongoing); MedAlliance: Grants/Research Support Recipient (Ongoing), Honoraria (Ongoing); Medtronic Cardiovascular: Contracted Research (Ongoing), Honoraria (Ongoing); Recor: Grants/Research Support Recipient (Ongoing); Terumo Corporation: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Kendra J. Grubb, MD: 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

Michael H. Joner, MD: Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 22, 2022); Alchimedics S.A.S.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 15, 2022); Biotronik: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiac Dimensions: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing); InfraRedx: Grant/Research Support (Ongoing); ReCor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 19, 2022); Shockwave: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Veryan: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing)

Thomas E. MacGillivray, MD: No financial relationships to disclose

Vinod Thourani, MD, FACC, FACS: Abbott Vascular, Artivion, Edwards, Boston Scientific, Jenavalve, Shockwave: Advisor (Ongoing); DASI Simulations: Intellectual Property/Patents (Ongoing)